Results 121 to 130 of about 909,959 (268)

Molecular Diagnostics in Pathology [PDF]

Archives of Pathology & Laboratory Medicine, 2018
openaire   +2 more sources

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

Molecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park, Kyongman An, Gyeonghwa Kim, Soo‐Nyun Choi, Hong‐Ki Lee, Keun Hur, Kyu‐Shik Jeong   +6 more
wiley   +1 more source

Special Issue "Inflammatory Airway Diseases: Diagnosis, Pathology, Molecular Mechanisms and Treatment Options". [PDF]

Int J Mol Sci
Matthews E, Krick S.
europepmc   +1 more source

Oligodendroglioma: pathology, molecular mechanisms and markers. [PDF]

Acta Neuropathol, 2015
Wesseling P, van den Bent M, Perry A.
europepmc   +1 more source

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source

Research Progress on Pathology, Molecular Mechanisms, and Intervention Strategies of Cognitive Dysfunction Associated with Type 2 Diabetes. [PDF]

Int J Gen Med
Zhou H, Ran Y, Jiang Y, Li R.
europepmc   +1 more source

Zika virus: An update on epidemiology, pathology, molecular biology, and animal model. [PDF]

J Med Virol, 2016
Ramos da Silva S, Gao SJ.
europepmc   +1 more source

Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant, Tise Suzuki, Kiera McGivney, V. S. S. Abhinav Ayyadevara, Sharon Asariah, Jay Deng, Ethan Nyein, Jacqueline Coats, Gary Yu, Yevgeniya J. Ioffe, Christian Hurtz, Juli J. Unternaehrer   +11 more
wiley   +1 more source

Carcinosarcoma of the Endometrium-Pathology, Molecular Landscape and Novel Therapeutic Approaches. [PDF]

Medicina (Kaunas)
Kostov S, Kornovski Y, Ivanova V, Dzhenkov D, Metodiev D, Wafa M, Ivanova Y, Slavchev S, Tsoneva E, Yordanov A.   +9 more
europepmc   +1 more source

Pilocytic astrocytoma: pathology, molecular mechanisms and markers. [PDF]

Acta Neuropathol, 2015
Collins VP, Jones DT, Giannini C.
europepmc   +1 more source